372 related articles for article (PubMed ID: 23446204)
21. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A
Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of metabolic response with
Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
[TBL] [Abstract][Full Text] [Related]
23. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
Matsumoto I; Oda M; Takizawa M; Waseda R; Nakajima K; Kawano M; Mochizuki T; Ikeda H; Watanabe G
Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of
Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
[TBL] [Abstract][Full Text] [Related]
26. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
27. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors.
Kanou T; Funaki S; Minami M; Ose N; Kimura T; Fukui E; Watabe T; Shintani Y
Thorac Cancer; 2022 Jun; 13(11):1651-1656. PubMed ID: 35460177
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
[TBL] [Abstract][Full Text] [Related]
30. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
[TBL] [Abstract][Full Text] [Related]
31. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
El-Bawab HY; Abouzied MM; Rafay MA; Hajjar WM; Saleh WM; Alkattan KM
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):395-9. PubMed ID: 20639307
[TBL] [Abstract][Full Text] [Related]
32. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
Viti A; Terzi A; Bianchi A; Bertolaccini L
Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
[TBL] [Abstract][Full Text] [Related]
33. Recurrent thymoma: radiological (CT and FDG-PET) and histological (WHO criteria) features.
Ito H; Shimada K; Isogami K; Kondo T; Kaneta T; Takahashi S; Fukuda H
Radiat Med; 2006 May; 24(4):292-6. PubMed ID: 16958404
[TBL] [Abstract][Full Text] [Related]
34. 18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma.
Shibata H; Nomori H; Uno K; Sakaguchi K; Nakashima R; Iyama K; Tomiyoshi K; Kaji M; Goya T; Suzuki T; Horio H
Cancer; 2009 Jun; 115(11):2531-8. PubMed ID: 19326456
[TBL] [Abstract][Full Text] [Related]
35. The utility of FDG-PET in the diagnosis of thymic epithelial tumors.
Otsuka H
J Med Invest; 2012; 59(3-4):225-34. PubMed ID: 23037192
[TBL] [Abstract][Full Text] [Related]
36. Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome.
Ried M; Potzger T; Sziklavari Z; Diez C; Neu R; Schalke B; Hofmann HS
Thorac Cardiovasc Surg; 2014 Mar; 62(2):161-8. PubMed ID: 23775415
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of Preoperative
Ishibashi M; Tanabe Y; Yunaga H; Miyoshi H; Miwa K; Nakamura H; Fujii S; Ogawa T
Yonago Acta Med; 2019 Mar; 62(1):146-152. PubMed ID: 30962757
[TBL] [Abstract][Full Text] [Related]
38. Analysis of surgical treatment of Masaoka stage III-IV thymic epithelial tumors.
Hamanaka K; Koyama T; Matsuoka S; Takeda T; Miura K; Yamada K; Hyogotani A; Seto T; Okada K; Ito KI
Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):731-735. PubMed ID: 30132223
[TBL] [Abstract][Full Text] [Related]
39. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
[TBL] [Abstract][Full Text] [Related]
40. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
Zhao J; Wang H; Li Q
Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
